(Q28241622)

English

A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery

scientific article (publication date: 2004)

In more languages
default values for all languages
No label defined

No description defined

Statements

A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery (English)
0 references
D C H Cheng
0 references
C D Mazer
0 references
R Martineau
0 references
A Ralph-Edwards
0 references
J Karski
0 references
J Robblee
0 references
B Finegan
0 references
R I Hall
0 references
R Latimer
0 references
A Vuylsteke
0 references
January 2004
0 references
127
0 references
1
0 references
79-86
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit